proline has been researched along with Non-alcoholic Fatty Liver Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Ba, G; Bao, T; Cho, S; Dai, L; Fu, M; Jin, W; Laxi, N; Qi, R; Yu, H; Zhang, J | 1 |
| Jiang, H; Li, J; Tu, H; Wen, J; Wu, W; Yin, X; Zhai, B | 1 |
| Hu, Q; Hua, C; Huo, G; Jiang, H; Li, S; Wu, Y; Zhou, F; Zhu, H | 1 |
| Banno, A; Kiriyama, K; Matsuba, S; Mijiti, M; Mori, R; Nagaoka, S; Nakashima, Y; Sutoh, K; Takeuchi, A; Ye, Y | 1 |
| Bae, SC; Lee, YH; Song, GG | 1 |
| Aliani, M; House, JD; Mayengbam, S; Raposo, S | 1 |
| Ammendolia, DA; Dornbos, P; Fader, KA; Harkema, JR; Kumagai, K; Lunt, SY; Matthews, J; Nault, R; Potter, D; Sharratt, B; Zacharewski, T | 1 |
1 review(s) available for proline and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Meta-analysis of associations between the peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism and susceptibility to nonalcoholic fatty liver disease, rheumatoid arthritis, and psoriatic arthritis.
Topics: Alanine; Arthritis, Psoriatic; Arthritis, Rheumatoid; Genetic Predisposition to Disease; Humans; Non-alcoholic Fatty Liver Disease; Polymorphism, Genetic; PPAR gamma; Proline | 2014 |
6 other study(ies) available for proline and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Hepatoprotective Effects of
Topics: Animals; Asteraceae; Diet, High-Fat; Gastrointestinal Microbiome; Mice; Non-alcoholic Fatty Liver Disease; Plant Extracts; Proline; RNA, Ribosomal, 16S | 2022 |
Glutaminase 1 blockade alleviates nonalcoholic steatohepatitis via promoting proline metabolism.
Topics: Animals; Fatty Acids; Glutaminase; Glutamine; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Proline | 2022 |
Topics: Agaricales; Animals; Antioxidants; Arginine; Biomarkers; Diet, High-Fat; Fucose; Galactose; Glucose; Glycerides; Glycerol; Isoleucine; Leucine; Lipid Metabolism; Lipid Metabolism Disorders; Liver; Mannose; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Phospholipids; Polysaccharides; Proline; Spectroscopy, Fourier Transform Infrared; Steroids; Valine; Xylose | 2022 |
Protamine-derived peptide RPR (Arg-Pro-Arg) ameliorates oleic acid-induced lipogenesis via the PepT1 pathway in HepG2 cells.
Topics: Hep G2 Cells; Humans; Lipogenesis; Non-alcoholic Fatty Liver Disease; Oleic Acid; Peptide Transporter 1; Peptides; Proline; Protamines | 2023 |
Oral exposure to the anti-pyridoxine compound 1-amino D-proline further perturbs homocysteine metabolism through the transsulfuration pathway in moderately vitamin B₆ deficient rats.
Topics: Animals; Asymptomatic Diseases; Biomarkers; Cystathionine; Cystathionine gamma-Lyase; Diet; Disease Models, Animal; Disease Progression; Flax; Homocysteine; Hyperhomocysteinemia; Liver; Male; Non-alcoholic Fatty Liver Disease; Proline; Pyridoxal Phosphate; Pyridoxine; Random Allocation; Rats, Sprague-Dawley; Seeds; Vitamin B 6; Vitamin B 6 Deficiency | 2015 |
Dose-Dependent Metabolic Reprogramming and Differential Gene Expression in TCDD-Elicited Hepatic Fibrosis.
Topics: Animals; Ascorbic Acid; Cellular Reprogramming; Chemical and Drug Induced Liver Injury; Collagen; Cytokines; Dose-Response Relationship, Drug; Energy Metabolism; Extracellular Matrix; Female; Gene Expression Regulation; Glucose; Glycogen; Inflammation Mediators; Liver; Liver Cirrhosis; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Polychlorinated Dibenzodioxins; Proline; Time Factors; Transcriptome | 2016 |